Search Results for "Teratogenicity Test Of Montelukast"
Original Source: Fexofenadine Hydrochloride [Major Pharmaceuticals]
These highlights do not include all the information needed to use fexofenadine hydrochloride safely and effectively. See full prescribing information for fexofenadine hydrochloride. Fexofenadine Hydrochloride Tablets. Initial
Matching Channels
The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...
Matching News
Dr Reddy's launches montelukast granules in the US
Dr Reddy's Laboratories has launched montelukast sodium oral granules 4mg, a generic version of Merck & Co's allergy and asthma drug Singulair, on the US market. The Indian company had last month laun...
What Is Singulair (Montelukast)?
Singulair (montelukast) is a prescription medication for the prevention of asthma attacks for patients aged 12 months or more (adults and children). Montelukast is an LTRA (leukotriene receptor antago...
Dr. Reddy's unveils montelukast sodium oral granules
Dr. Reddy's Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market.
Dr. Reddy's introduces generic Singulair oral granules in the U.S.
Dr. Reddy's Laboratories announced today that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules in the US market on Sept...
Montelukast does not improve symptoms in wheezy infants
NEW YORK (Reuters Health) - The leukotriene-receptor antagonist montelukast does not improve respiratory symptoms or lung function in wheezy infants.
Montelukast improves respiratory disturbance and adenoid size in children with OSA
Ben-Gurion University of the Negev (BGU) researchers revealed that a majority of children suffering from Obstructive Sleep Apnea (OSA) treated with montelukast, a drug approved for asthma or hay fever...
Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Mo...
Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis
Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provid...
Matching PubMed Articles
Risk Factors for Montelukast Treatment Failure in Step-Down Therapy for Controlled Asthma.
Background. Leukotriene receptor antagonists including montelukast are an option for step-down therapy for mild asthmatics controlled on low-dose inhaled corticosteroids (ICS). Because some patients f...
Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers.
OBJECTIVE: Montelukast, a leukotriene receptor antagonist, is used in the treatment of asthma. The objective of the study reported here was to determine whether multiple doses of clarithromycin or flu...
Background. The efficacy of oral montelukast has been well established in asthma and allergic rhinitis in adults and children. The purpose of this study was to evaluate dose-related bronchodilation an...
Beneficial Effects of Montelukast against Cisplatin-Induced Acute Renal Damage in Rats.
Objective: In this study, the therapeutic and protective effects of montelukast against cisplatin (CP)-induced acute renal damage were investigated. Materials and Methods: Thirty-five female rats were...
Efficacy of montelukast as added therapy in patients with chronic idiopathic urticaria.
Chronic idiopathic urticaria is a common skin disorder characterized by recurrent appearance of wheals and/or angioedema for more than 6 weeks without an identifiable cause. Consensus guidelines sugge...
